Industry news

Russian pharmaceutical industry shines at the BIO International Convention 2013

Modern Russia

The Russian pharmaceutical industry made its mark at this year’s BIO International Convention in Chicago. Sergey Tsyb, Director of the Department of Chemical Industries and Bioengineering Technologies at the Russian Ministry of Industry and Trade, highlighted the government’s strategy for Russian pharmaceutical development at the “Spotlight on the BRICS: Russia” session on Monday.

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Reuters

Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday.

New retraining program for biotech specialists announced

Marchmont Innovation News

The Rusnano InfraFund and Nanolek, a biotech company set up by Russia’s nanotech giant, will invest on a par basis in excess of $530,000 in the development and implementation of a vocational retraining program for specialists working on immunobiological drugs and related technologies, Rusnano announced  earlier this week. 

Russia to participate in setting up of NMIZs

Business Standard

The government is offering a host of incentives like exemption from capital gains tax and a liberalised labour and environment norms to promote these zones.

Rusnano asset and Pfizer to develop and market new drugs

Marchmont Innovation News

BIND Therapeutics, a biotech asset of Russia’s Rusnano, has inked an agreement with Pfizer, a global pharma major, on the joint development and sales of innovation drugs, including cancer ones, Rusnano  announced . 
 

EBRD supports Russian pharmaceutical industry

EBRD

A Russian-owned and managed pharmaceutical company, GEROPHARM-Bio, a subsidiary of OOO Geropharm, has obtained a five-year EBRD loan to finance part of the cost of expanding and modernising of its production plant at Obolensk in the Moscow region in order to help it comply with international standards.

Drug-company data vaults to be opened

Daniel Cressey, Nature.com

European agency will publish firms’ clinical-trial results. 

International calls for the pharmaceutical industry to share the results of clinical trials have grown ever more intense amid revelations that high-profile companies have hidden crucial data on safety and efficacy. Now Europe is moving towards measures that would significantly increase disclosure of such data.

A technopark for small and medium businesses to appear in Kaluga Region

Venture News

The project of a technopark for small and medium businesses has been designed on the model of existing industrial parks for major investors. The concept of the park to appear in Kaluga Region has been approved by the Architects Board under the Governor. 

Here Are 3 Things Big Pharma Must Do To Survive - Joseph Jimenez

Max Nisen, Business Insider

After years of relative stability and high profits, things aren't looking particularly rosy for the pharmaceutical industry. Blockbuster drugs are losing patent protection, R&D efforts haven't paid off as hoped, and prices will come under pressure from the Affordable Care Act.

New Far East medical center may expect equipment from Rusnano or Japanese

Marchmont Innovation News

Rusnano, Russia’s nanotech giant, is ready to join as a co-investor whatever private-public partnership (PPP) may form to equip the new high tech medical center to soon open at Vladivostok-based Far East Federal University (FEFU), the first such center in the Primorsky region in Russia’s Far East